Manufacturer record
Abicee Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Abicee Pharmaceuticals Pvt. Ltd (Odisha) were declared Not of Standard Quality between April 2020 and September 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 2718, Alumina, Magnesia & Simethicone Tablets U.S.P. (exp Nov 2023). CDL Kolkata (CDSCO lab) found it not of standard quality: Assay of Simethicone. Listed in the September 2022 alert.
Records by type
2 records linked to Abicee Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Alumina, Magnesia & Simethicone Tablets U.S.P. | Batch 2718Mfg Dec 2021 · Exp Nov 2023 | Assay of SimethiconeAssay | CDL KolkataCDSCO lab | Sep 2022 |
| Riboflavine Tablets I.P. 10 mg | Batch 2308Mfg Oct 2019 · Exp Mar 2021 | DescriptionDescription | CDL KolkataCDSCO lab | Apr 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.